Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 9NETWORK 8INDUSTRY 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Extravasations of Anthracycline Anti-cancer Agents 1Extravasation 1Anthracycline Extravasation 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Dexrazoxane × Clear all
NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Thermosome GmbH

Phase 1 Completed
8 enrolled
Sarcoma

Sarcoma

NCT00548561 2015-10-21

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
23 enrolled

Anthracycline Extravasation

NCT00548704 2015-10-21

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
57 enrolled

Extravasation

NCT01596088 2015-04-07

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Kissei Pharmaceutical Co., Ltd.

Phase 1/2 Completed
2 enrolled 6 charts

Extravasations of Anthracycline Anti-cancer Agents

Data powered by HemOnc (CC BY 4.0) Colophon âš¡